�㽶��Ƶ News - Alzheimer's disease

Caring Conversations - Home care or care home?

webfull — Thu, 31 Oct 2024 18:51:13 +0000

Caring Conversations is an online forum for care partners of people living with dementia to learn from experts, share concerns and ask questions.

Published: 31 October 2024

Experts: World Alzheimer Report 2024

webfull — Wed, 18 Sep 2024 19:48:58 +0000

A new edition of World Alzheimer Report, to be published Sept. 20, 2024, will take a deep dive into how perceptions of dementia have changed over the past five years. It builds on a 2019 report that found one in four people believed nothing could be done to prevent dementia, while evidence suggests 40 per cent of cases could be delayed or prevented by addressing modifiable risk factors.

Published: 18 September 2024

January is Alzheimer's Awareness Month in Canada

webfull — Fri, 26 Jan 2024 19:51:36 +0000

We have a multitude of free resources on management of the illness, aspects of care, caregiving and other related topics.

Published: 26 January 2024

The stomach bug that may raise your risk of Alzheimer’s disease

webfull — Wed, 20 Dec 2023 14:18:28 +0000

A common stomach bacteria found in two thirds of the world population may be linked to a higher risk of Alzheimer’s disease, new research suggests.

Published: 20 December 2023

A more convenient and accessible way to diagnose Alzheimer’s disease?

webfull — Thu, 20 Apr 2023 14:00:13 +0000

Despite extensive research and encouraging findings, Alzheimer’s disease (AD) remains difficult to diagnose based on signs and symptoms alone. But what if one day, a blood sample during an annual check-up could be used to identify the disease? A recent McGill-led study has found that a new kind of blood test is as effective at detecting AD as lumbar punctures, one of the current methods used to diagnose AD.

Published: 20 April 2023

Study finds obesity-related neurodegeneration mimics Alzheimer’s disease

webfull — Tue, 31 Jan 2023 14:00:06 +0000

Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groups

A new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of �㽶��Ƶ finds a correlation between neurodegeneration in obese people and Alzheimer’s disease (AD) patients.

Published: 31 January 2023

New clinical trial: Keeping brains fit longer

webfull — Mon, 30 Jan 2023 15:36:50 +0000

New research at The Neuro is studying a targeted brain training program and a potential new treatment for early Alzheimer’s.

For more information on these two studies, contact the neurocognitive team at the Clinical Research Unit at The Neuro at info-cru.neuro [at] mcgill.ca or visit cru.mcgill.ca/ad_en.

Published: 30 January 2023

New partnership: Dementia-Friendly Canada

webfull — Tue, 20 Dec 2022 16:17:21 +0000

What is Dementia-Friendly Canada?

The Dementia-Friendly Canada project is a partnership between the Alzheimer Societies of Canada, British Columbia, Saskatchewan, Manitoba and Ontario and is intended to foster the creation of dementia-friendly communities across the country.

Published: 20 December 2022

The Amelia and Lino Saputo Foundation to donate $1.5M to support health sciences education at �㽶��Ƶ

webfull — Thu, 02 Jun 2022 12:56:05 +0000

This visionary support will enable the new Office of Ed-TECH to expand opportunities for online learning in dementia education and other community-based and professional training initiatives

A generous commitment of $1.5 million from the Amelia and Lino Saputo Foundation will support innovative teaching at the new Office of Ed-TECH (Education Technology and E-Learning Collaboration for Health) at the McGill Faculty of Medicine and Health Sciences (FMHS) under the umbrella of the Amelia Saputo Community Outreach for Dementia Care.

Published: 2 June 2022

Experts: FDA approves much-debated Alzheimer's drug panned by experts

webfull — Thu, 10 Jun 2021 14:35:58 +0000

U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer's patients. (CTV News)

Published: 10 June 2021